How Companies in Chile Can Source Pharma Products & CDMO Services (2026 Guide)
Chile • Source Pharma Products & CDMO Services
Introduction
Chile relies heavily on imported medicines and APIs, and its regulator places strong emphasis on quality and therapeutic equivalence. Importers, distributors, pharmacy chains and public buyers source finished generics, sterile injectables, biologics and contract manufacturing (CDMO) services from many regions, helped by free trade agreements with most major supply bases.
This guide explains where Chilean buyers typically source, how to qualify a foreign supplier for the Instituto de Salud Pública de Chile (ISP) and its national medicines agency (ANAMED), which import documents you need, and how to handle the problems that slow supply. For market context, see our overview of the Chilean pharmaceutical market and the Chile country hub.
Where supply comes from
Chilean buyers usually spread supply across several regions, choosing sources by product complexity, price and the regulatory record of the site.
| Supply base | What buyers typically source | What to check |
|---|---|---|
| India and China | Generic APIs, intermediates and many finished generics | GMP evidence, bioequivalence data accepted by ISP, impurity profiles |
| Europe (EU-GMP) | Complex generics, sterile injectables, hormones, specialty and orphan products | EU-GMP certificate, Spanish packaging capacity |
| United States | Specialty, biologic and high-value hospital products | FDA inspection history, COPP availability |
| Argentina, Brazil, Mexico and Colombia | Finished generics with Spanish packs, regional brands, contract packaging | Regional trade agreements, existing Latin American registrations |
| South Korea and Japan | Biosimilars and specialty injectables | Cold chain planning for trans-Pacific routes |
Chile is a relatively small market with many registered products, so suppliers that already have Spanish artwork and bioequivalence data for Latin America often move faster than lower-priced sites starting from scratch.
Pharma categories supply
- Finished generics: tablets, capsules and oral liquids for chronic disease. Many must show bioequivalence to be marketed as interchangeable, and pharmacies display the bioequivalence logo on these products.
- APIs and excipients: for the local manufacturing and compounding sector.
- Sterile injectables and oncology: vials, ampoules and prefilled syringes for public and private hospitals.
- Biologics and high-cost treatments: including products financed under Law 20.850 (Ricarte Soto Law) for high-cost conditions.
- OTC products and supplements: vitamins and food supplements, which follow different rules from medicines.
- CDMO and contract packaging: outsourced manufacture and local relabelling for distributors and brand owners.
How to source pharma products
- Define the product and route. Confirm the molecule, strength, dosage form and pack, and whether you need a new sanitary registration, a transfer of an existing one, or a provisional or patient-specific import.
- Confirm the registration holder. ISP registrations are held by a person or company domiciled in Chile. A foreign manufacturer supplies through a local importer or regulatory partner that acts as holder.
- Shortlist qualified sites. Ask for current GMP certificates (WHO-GMP, EU-GMP, US FDA or a PIC/S authority) and confirm they meet ISP requirements for the product type.
- Review the technical file. Request a CTD-structured dossier, CoAs for recent batches, stability data for the right conditions, and bioequivalence studies where ISP requires them, including the reference product used.
- Agree commercial terms. Settle MOQ, lead time, Incoterms, Spanish artwork and who pays for translations and legalisation.
- Test before scaling. Order samples or a pilot batch and test it locally before volume orders.
PharmaTradz works with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. You can post one structured requirement through our request for quotation page and compare offers from suitable sites. If you supply public buyers, see our government tender supply service.
Required documents for import
Medicine imports into Chile pass through two controls: ISP sanitary authorisation and clearance by the National Customs Service (Servicio Nacional de Aduanas). Prepare these documents before shipment.
Regulatory documents
- ISP sanitary registration of the product, or a provisional or patient-specific import authorisation
- Customs destination certificate (CDA) issued through ISP to release the goods from customs
- Use and disposal authorisation (uso y disposición) from ISP before the goods can be sold or distributed
- Certificate of Pharmaceutical Product (COPP) or free sale certificate, with Spanish translation where required
- GMP certificate of the manufacturing site, legalised or apostilled where needed
- Certificate of Analysis for each batch
Commercial and shipping documents
- Commercial invoice and packing list with batch numbers and expiry dates
- Bill of lading or air waybill
- Certificate of origin to claim free trade agreement preferences
- Temperature logs for cold-chain goods and safety data sheets for APIs
Goods cleared with a CDA must stay in an authorised warehouse until use and disposal is granted, so plan storage for that waiting period.
Logistics and shipping
Main entry points
- Sea: San Antonio and Valparaíso in central Chile handle most container imports and are close to Santiago. Northern ports such as Antofagasta and Iquique serve the north.
- Air: Arturo Merino Benítez International Airport in Santiago (SCL) is the main gateway for urgent and temperature-controlled pharmaceuticals.
Indicative transit times
| Origin | Sea freight to San Antonio or Valparaíso | Air freight to Santiago |
|---|---|---|
| East Asia | Typically 30 to 40 days across the Pacific | Typically 3 to 6 days |
| South Asia | Typically 35 to 50 days | Typically 3 to 7 days |
| Europe | Typically 30 to 40 days, often via the Panama Canal | Typically 1 to 3 days |
| Argentina and Brazil | Road freight across the Andes, typically under 10 days | Typically 1 to 2 days |
Cold chain, Incoterms and customs
Vaccines, biologics and many injectables need 2 to 8°C control throughout. Use GDP-qualified forwarders, validated packaging and data loggers, and book cold storage at Santiago airport in advance. Road crossings over the Andes can close in winter, so keep a sea or air fallback for regional supply. FCA or CIP terms are common for air freight and FOB or CIF for sea. A customs agent (agente de aduanas) handles the import declaration and coordinates the CDA with ISP.
Legal and regulatory overview
- Regulator: ISP, through ANAMED, under the Ministry of Health. The Health Code and Supreme Decree 3 of 2010 set the rules for registration and control of medicines.
- Registration holder: a person or company domiciled in Chile.
- GMP: manufacturing sites must show GMP compliance accepted by ISP.
- Bioequivalence: ISP requires therapeutic equivalence studies for many generics, using an ISP-listed reference product.
- Stability: WHO lists long-term conditions of 25°C/60% RH (Zone II) for Chile. If you also supply tropical markets, ask for Zone IVb data too.
- Labelling: labels and package inserts must be in Spanish and follow ISP requirements.
- Timelines: registration typically takes several months to more than a year, depending on the product and whether a fast-track route applies.
Public purchasing and special imports
CENABAST, the national health supply centre, buys medicines for the public network, and public hospitals also buy through the ChileCompra platform (Mercado Público). Both generally require a product registered with ISP. ISP can authorise provisional imports of unregistered medicines in specific cases, such as urgent need or individual patients with a prescription.
Common challenges and practical solutions
| Challenge | Practical solution |
|---|---|
| Bioequivalence gaps | Check which reference product ISP accepts before you choose a supplier, and ask for existing studies at the first contact. |
| Registration delays | File a complete dossier the first time and use suppliers with Latin American registration experience. |
| Spanish labels and inserts | Agree artwork ownership in the contract, and have the holder's technical team approve final proofs. |
| Goods held after customs clearance | Plan warehouse space and time for the use and disposal step before goods are sold. |
| Long sea transits | Plan production and shipping three to four months ahead and hold safety stock of critical items. |
| Small order volumes | Look for suppliers with flexible MOQs, or combine Chilean volumes with other Latin American markets. |
Conclusion
Sourcing for Chile works best when the registration route and bioequivalence evidence are settled before price talks. Confirm the local holder, check the reference product, confirm GMP evidence, and then compare offers across regions. Asian sources are strong on generic APIs and volume products, while European and US sites remain common for complex sterile and biologic products.
PharmaTradz helps Chilean importers, distributors and public suppliers reach qualified manufacturers in every major region. To check a site's credentials, read our guide on how to check a WHO-GMP certificate.
Frequently Asked Questions
Who regulates medicine imports in Chile?
The Instituto de Salud Pública (ISP), through its national medicines agency ANAMED, registers medicines and controls their import. Customs clearance is handled by the National Customs Service.
Can a foreign manufacturer hold a sanitary registration in Chile?
Not directly. The holder must be a person or company domiciled in Chile, usually the importer or a regulatory partner.
What are the CDA and use and disposal steps in Chile?
The CDA lets imported medicines leave customs for an authorised warehouse. The use and disposal authorisation from ISP then allows the goods to be sold or distributed.
Do generics need bioequivalence studies in Chile?
Many do. ISP requires therapeutic equivalence studies for a wide list of molecules, measured against an ISP-listed reference product.
Which stability conditions apply to Chile?
WHO lists 25°C/60% RH (Zone II) as the long-term condition for Chile. Confirm the requirement for your product with the registration holder.
How does CENABAST buy medicines?
CENABAST buys on behalf of the public health network through public tenders, and products generally need a valid ISP registration to take part.
More on Chile
Source Pharma Products & CDMO Services — other markets
Planning to register or source in Chile?
Tell us the molecule, dosage form and target market. We will come back on the regulatory pathway and whether the project is realistic before you commit anything.
Submit a Requirement Ask a questionIf you already hold WHO-GMP, EU-GMP, USFDA or PIC/S approval, you are closer to supplying Chile than you probably think.
Chile's regulator publishes a register of authorised products. Look up any supplier's claims yourself — including ours.
